VanEck Associates’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $58.9M | Sell |
1,066,648
-127,719
| -11% | -$6.92M | 0.04% | 249 |
|
|
2025
Q4 | $58.6M | Buy |
1,194,367
+540,104
| +83% | +$25.2M | 0.05% | 226 |
|
|
2025
Q3 | $28.2M | Sell |
654,263
-59,590
| -8% | -$2.33M | 0.03% | 306 |
|
|
2025
Q2 | $27.4M | Sell |
713,853
-95,812
| -12% | -$3.66M | 0.03% | 296 |
|
|
2025
Q1 | $31.4M | Sell |
809,665
-34,374
| -4% | -$1.26M | 0.04% | 249 |
|
|
2024
Q4 | $28.5M | Buy |
844,039
+107,529
| +15% | +$3.87M | 0.04% | 262 |
|
|
2024
Q3 | $28M | Buy |
736,510
+56,843
| +8% | +$2.33M | 0.03% | 252 |
|
|
2024
Q2 | $26.2M | Buy |
679,667
+81,233
| +14% | +$3.42M | 0.04% | 241 |
|
|
2024
Q1 | $25.7M | Buy |
598,434
+68,846
| +13% | +$2.84M | 0.04% | 235 |
|
|
2023
Q4 | $19.6M | Sell |
529,588
-56,593
| -10% | -$2.03M | 0.04% | 249 |
|
|
2023
Q3 | $21.2M | Buy |
586,181
+67,892
| +13% | +$2.41M | 0.05% | 232 |
|
|
2023
Q2 | $18.5M | Buy |
518,289
+10,418
| +2% | +$374K | 0.04% | 257 |
|
|
2023
Q1 | $18.1M | Sell |
507,871
-236,042
| -32% | -$8.26M | 0.04% | 254 |
|
|
2022
Q4 | $26.1M | Sell |
743,913
-74,421
| -9% | -$2.48M | 0.07% | 208 |
|
|
2022
Q3 | $24.1M | Buy |
818,334
+329,988
| +68% | +$12.5M | 0.07% | 201 |
|
|
2022
Q2 | $26.6M | Buy |
488,346
+175,474
| +56% | +$9.69M | 0.07% | 212 |
|
|
2022
Q1 | $17M | Buy |
312,872
+14,133
| +5% | +$768K | 0.04% | 281 |
|
|
2021
Q4 | $16.5M | Buy |
298,739
+3,433
| +1% | +$179K | 0.04% | 282 |
|
|
2021
Q3 | $14.1M | Buy |
295,306
+80,207
| +37% | +$4.03M | 0.04% | 300 |
|
|
2021
Q2 | $10.7M | Sell |
215,099
-19,221
| -8% | -$924K | 0.03% | 339 |
|
|
2021
Q1 | $10.5M | Sell |
234,320
-5,313
| -2% | -$241K | 0.03% | 333 |
|
|
2020
Q4 | $11M | Buy |
239,633
+25,658
| +12% | +$1.18M | 0.03% | 291 |
|
|
2020
Q3 | $10.1M | Sell |
213,975
-8,552
| -4% | -$428K | 0.03% | 262 |
|
|
2020
Q2 | $11.3M | Buy |
222,527
+35,897
| +19% | +$1.84M | 0.04% | 239 |
|
|
2020
Q1 | $8.84M | Buy |
186,630
+15,856
| +9% | +$846K | 0.04% | 238 |
|
|
2019
Q4 | $10M | Buy |
170,774
+29,455
| +21% | +$1.64M | 0.04% | 260 |
|
|
2019
Q3 | $7.54M | Sell |
141,319
-29,232
| -17% | -$1.5M | 0.04% | 262 |
|
|
2019
Q2 | $8.53M | Sell |
170,551
-14,795
| -8% | -$742K | 0.04% | 247 |
|
|
2019
Q1 | $9.68M | Sell |
185,346
-79,300
| -30% | -$3.96M | 0.05% | 220 |
|
|
2018
Q4 | $12.6M | Sell |
264,646
-9,392
| -3% | -$463K | 0.06% | 205 |
|
|
2018
Q3 | $13.8M | Sell |
274,038
-705
| -0.3% | -$35.8K | 0.07% | 215 |
|
|
2018
Q2 | $13.8M | Buy |
274,743
+5,937
| +2% | +$299K | 0.06% | 209 |
|
|
2018
Q1 | $13.1M | Sell |
268,806
-42,299
| -14% | -$1.97M | 0.07% | 213 |
|
|
2017
Q4 | $13.8M | Buy |
311,105
+36,336
| +13% | +$1.68M | 0.07% | 208 |
|
|
2017
Q3 | $13.9M | Buy |
274,769
+25,289
| +10% | +$1.28M | 0.07% | 213 |
|
|
2017
Q2 | $13.4M | Sell |
249,480
-74,145
| -23% | -$3.95M | 0.07% | 204 |
|
|
2017
Q1 | $17.1M | Buy |
323,625
+48,569
| +18% | +$2.46M | 0.08% | 180 |
|
|
2016
Q4 | $13.2M | Buy |
275,056
+56,630
| +26% | +$2.8M | 0.07% | 183 |
|
|
2016
Q3 | $11.8M | Sell |
218,426
-30,097
| -12% | -$1.65M | 0.05% | 190 |
|
|
2016
Q2 | $13.5M | Sell |
248,523
-10,755
| -4% | -$567K | 0.07% | 169 |
|
|
2016
Q1 | $13.1M | Sell |
259,278
-107,062
| -29% | -$5.33M | 0.09% | 147 |
|
|
2015
Q4 | $18.5M | Buy |
366,340
+31,957
| +10% | +$1.63M | 0.15% | 139 |
|
|
2015
Q3 | $16.1M | Sell |
334,383
-26,435
| -7% | -$1.38M | 0.12% | 140 |
|
|
2015
Q2 | $18.8M | Buy |
360,818
+74,536
| +26% | +$4.2M | 0.11% | 152 |
|
|
2015
Q1 | $16.5M | Sell |
286,282
-14,726
| -5% | -$844K | 0.1% | 166 |
|
|
2014
Q4 | $16.1M | Sell |
301,008
-38,521
| -11% | -$2.16M | 0.1% | 160 |
|
|
2014
Q3 | $19.5M | Buy |
339,529
+91,435
| +37% | +$5.61M | 0.1% | 149 |
|
|
2014
Q2 | $16.6M | Buy |
248,094
+18,557
| +8% | +$1.26M | 0.08% | 160 |
|
|
2014
Q1 | $15.3M | Buy |
229,537
+32,632
| +17% | +$2.21M | 0.08% | 158 |
|
|
2013
Q4 | $13.1M | Buy |
196,905
+9,885
| +5% | +$641K | 0.07% | 164 |
|
|
2013
Q3 | $11.7M | Sell |
187,020
-15,884
| -8% | -$1.02M | 0.06% | 161 |
|
|
2013
Q2 | $12.7M | Buy |
+202,904
| New | +$12.9M | 0.07% | 135 |
|
Other funds holding GSK
JEST
